Quantcast
Last updated on April 18, 2014 at 7:49 EDT

Latest Paul Greengard Stories

2013-09-19 23:38:35

Texas Children’s Hospital is excited to announce that on December 5, 2013, Dr. Huda Zoghbi, a geneticist at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute will be honored with the 2013 Pearl Meister Greengard Prize. Houston, TX (PRWEB) September 18, 2013 Dr. Huda Zoghbi, a ground-breaking geneticist at Baylor College of Medicine (http://www.bcm.edu) and the Jan and Dan Duncan Neurological Research Institute (http://www.nri.texaschildrens.org) at...

2013-09-09 16:23:57

HOUSTON, Sept. 9, 2013 /PRNewswire-USNewswire/ -- Dr. Huda Zoghbi (http://www.bcm.edu/genetics/index.cfm?pmid=11053), a ground-breaking geneticist at Baylor College of Medicine (www.bcm.edu) and the Jan and Dan Duncan Neurological Research Institute (www.nri.texaschildrens.org) at Texas Children's Hospital, will receive the 2013 Pearl Meister Greengard Prize (http://greengardprize.rockefeller.edu) from The Rockefeller University in a ceremony on Dec. 5. The prize, established by...

2013-09-09 16:23:29

Celebrating 10 Years of Honoring the Achievements of Women in Science NEW YORK, Sept. 9, 2013 /PRNewswire-USNewswire/ -- The Rockefeller University announced today that Huda Y. Zoghbi, M.D., will receive the 10(th) annual Pearl Meister Greengard Prize--one of the world's preeminent honors recognizing outstanding achievements by women in science. Dr. Zoghbi was chosen by a selection committee of ten members, including five Nobel laureates and two recipients of the Breakthrough Prize...

2012-12-04 12:25:28

NEW YORK, Dec. 4, 2012 /PRNewswire-USNewswire/ -- The Fisher Center for Alzheimer's Research Foundation (ALZinfo.org) today announced it has received the highest 4-star rating for the second consecutive year from Charity Navigator's, the nation's premier charity evaluator. Only 17% of the charities rated by Charity Navigator have received 2 or more consecutive 4-star evaluations, indicating that Fisher Center for Alzheimer's Research Foundation outperforms most other charities in America....

2012-09-10 14:24:17

$100,000 prize honors female scientists who have made extraordinary contributions to biomedical science NEW YORK, Sept. 10, 2012 /PRNewswire-USNewswire/ -- Joan A. Steitz, Ph.D., a pioneer in the field of RNA biology whose discoveries involved patients with a variety of autoimmune diseases, will be awarded the 2012 Pearl Meister Greengard Prize from The Rockefeller University. The prize, which honors female scientists who have made extraordinary contributions to biomedical science and...

2011-11-07 11:26:00

NEW YORK, Nov. 7, 2011 /PRNewswire-USNewswire/ -- The Fisher Center for Alzheimer's Research Foundation (ALZinfo.org) today announced it has received a four-star rating from Charity Navigator, the nation's premier charity evaluator. The rating is based on a review of fiscal management and commitment to accountability and transparency. This highest rating, four-stars, reflects the leadership the Fisher Center for Alzheimer's Research Foundation has demonstrated in executing its...

2011-11-04 13:00:00

$100,000 prize honors female scientists who have made extraordinary contributions to biomedical science NEW YORK, Nov. 4, 2011 /PRNewswire-USNewswire/ -- Brenda Milner, Ph.D., a pioneer in the field of cognitive neuroscience whose discoveries revolutionized the understanding of memory, was awarded the 2011 Pearl Meister Greengard Prize from The Rockefeller University yesterday. The prize, which honors female scientists who have made extraordinary contributions to biomedical science and...

2011-04-25 16:38:32

Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, taken for depression and obsessive-compulsive disorder and anxiety disorders. This surprising discovery,...

2011-04-25 14:00:00

NEW YORK, April 25, 2011 /PRNewswire-USNewswire/ -- Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, taken for depression and obsessive-compulsive...

2011-03-16 18:30:21

Cells, which employ a process called autophagy to clean up and reuse protein debris leftover from biological processes, were the original recyclers. A team of scientists from Paul Greengard's Rockefeller University laboratory have linked a molecule that stimulates autophagy with the reduction of one of Alzheimer's disease's major hallmarks, amyloid peptide. Their finding suggests a mechanism that could be used to eliminate built-up proteins in diseases such as Alzheimer's, Down syndrome,...